NI
ACHN

Numeric Investors’s Achillion Pharmaceuticals ACHN Stock Holding History

Numeric Investors’s Portfolio ACHN Stock Details ACHN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2017
Q4 		$5.63M Sell
1,953,864
-443,228
-18% -$1.61M 0.04% 394
2017
Q3 		$10.8M Sell
2,397,092
-538,252
-18% -$2.39M 0.08% 233
2017
Q2 		$13.5M Sell
2,935,344
-94,219
-3% -$379K 0.12% 181
2017
Q1 		$12.8M Buy
3,029,563
+303,075
+11% +$1.26M 0.12% 197
2016
Q4 		$11.3M Buy
2,726,488
+1,832,386
+205% +$9.74M 0.1% 214
2016
Q3 		$7.24M Buy
+894,102
New +$7.6M 0.07% 267
2015
Q3 		– Sell
-18,700
Closed -$166K – 1224
2015
Q2 		$166K Buy
+18,700
New +$177K ﹤0.01% 878
2015
Q1 		– Sell
-280,900
Closed -$3.44M – 1109
2014
Q4 		$3.44M Buy
+280,900
New +$3.43M 0.04% 276

Other funds holding ACHN

RI
RTW Investments New York $11.7B AUM 174.13% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
O
OrbiMed New York $5.4B AUM 163.13% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $552B AUM 44.19% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $1.15T AUM 47.82% 1-Year Est. Return
BBA
Baker Bros. Advisors New York $20B AUM 154.41% 1-Year Est. Return
Deutsche Bank
Deutsche Bank Frankfurt Am Main Ge, Germany $344B AUM 42.99% 1-Year Est. Return

Numeric Investors's ACHN Position: Q4 2017 in Review

Numeric Investors reduced its Achillion Pharmaceuticals (ACHN) stake by 18% in Q4 2017, selling an estimated $1.61M and leaving 1,953,864 shares worth $5.63M. The position accounts for 0.04% of the portfolio, ranked #394.

Numeric Investors first reported a position in ACHN in Q4 2014 and has held it in 8 quarters since. The position peaked at $13.5M in Q2 2017. 149 funds tracked by Wall St. Rank hold ACHN as of Q4 2017.

  • Numeric Investors held 1,953,864 shares of Achillion Pharmaceuticals worth $5.63M as of Q4 2017.
  • Numeric Investors sold 443,228 Achillion Pharmaceuticals shares in Q4 2017, an estimated $1.61M.
  • Achillion Pharmaceuticals made up 0.04% of Numeric Investors's portfolio in Q4 2017, its #394 holding.
  • Numeric Investors first reported a position in Achillion Pharmaceuticals in Q4 2014 and has held it in 8 quarters since.
  • Numeric Investors's Achillion Pharmaceuticals position peaked at $13.5M in Q2 2017.
  • 149 funds tracked by Wall St. Rank held Achillion Pharmaceuticals as of Q4 2017.

Based on Numeric Investors's 13F filing for Q4 2017, filed 14 Feb 2018.